Results 201 to 210 of about 156,553 (306)

Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature. [PDF]

J Clin Med
Kosowski M, Kocjan M, Mazurkiewicz M, Gamrot-Wrzoł M, Ryl S, Nowakowski K, Kawecki J, Kukulski T, Kawecki D, Morawiec-Migas B.   +9 more
europepmc   +1 more source

Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation [PDF]

, 2001
Calatzis, A., Schiffl, Helmut, Schramm, W., Spannagl, M., Toepfer, Marcel   +4 more
core   +1 more source

Successful use of haemoperfusion therapy in an adult horse with hepatic encephalopathy and cholangiohepatitis

Equine Veterinary Education, EarlyView.
Summary A 4‐year‐old, 520 kg, American Quarter Horse broodmare, approximately 90 days in foal, was presented to Texas A&M University Teaching Hospital for suspected liver disease. Based on clinicopathological values and hepatic abnormalities noted ultrasonographically, the mare was presumptively diagnosed with cholangiohepatitis.
A. C. Trimble, S. H. White‐Springer, S. Alpini, E. Rumfola, A. N. DiSilvestro, Y. Ueda, K. Hobbs   +6 more
wiley   +1 more source

Anticoagulation Therapy for Atrial Fibrillation After Transcatheter Aortic Valve Replacement: National Database Insights. [PDF]

J Am Heart Assoc
Takegawa K, Kanaoka K, Iwanaga Y, Sasano T, Nishioka Y, Myojin T, Noda T, Imamura T, Miyamoto Y.   +8 more
europepmc   +1 more source

Thrombin Generation in Pediatric Haemophilia A Patients on Extended Half‐Life FVIII versus Non‐FVIII Therapies

Haemophilia, EarlyView.
ABSTRACT Introduction The therapeutic landscape for patients with haemophilia A (PwHA) is rapidly evolving with the introduction of extended half‐life FVIII (EHL‐FVIII) and non‐FVIII therapies that mimic FVIII, such as emicizumab (EMI). Monitoring non‐factor therapies in the laboratory poses challenges; however, the thrombin generation assay (TGA) can ...
Jessica Garcia, Sean G. Yates, Ravi Sarode, Guy Young, Ayesha Zia   +4 more
wiley   +1 more source

Oral Anticoagulation Therapy: An Update on Usage and Costs in the Endemic COVID-19 Era. [PDF]

J Clin Med
Favaloro EJ, Pasalic L, Lippi G.
europepmc   +1 more source

Fostamatinib treatment for patients with antiphospholipid syndrome and low platelet count: A case series

British Journal of Haematology, EarlyView.
Ekaterina Balaian, Rosa Sonja Alesci, Sandra Marten, Julia‐Annabell Georgi, Christiane Naue, Martin Bornhäuser, Karolin Trautmann‐Grill   +6 more
wiley   +1 more source

New Hydrophilic Helixone Dialyzers as an Alternative for Hemodialysis Patients With Membrane Hypersensitivity Reactions: A Retrospective Single‐Cohort Study

Hemodialysis International, EarlyView.
ABSTRACT Background Synthetic dialysis membranes, particularly those composed of polysulfone blended with polyvinylpyrrolidone, are commonly used in hemodialysis due to their efficiency. However, hypersensitivity reactions—often atypical and not fitting traditional type A and B classifications—have increasingly been reported.
Víctor Joaquín Escudero‐Saiz, Elena Cuadrado‐Payán, Eugenia Castellote, Roxana Buri, Higini Cao, Silvia Collado, Lida Maria Rodas, Néstor Fontseré, José Jesús Broseta, Francisco Maduell   +9 more
wiley   +1 more source

Anticoagulation Therapy and Severe Traumatic Brain Injury: A Retrospective Cohort Study on Clinical Outcomes Using TriNetX. [PDF]

J Clin Med
Rasmussen S, Shaik K, Rawson C, Saloum A, Rahme R, Karsy M.   +5 more
europepmc   +1 more source

Anticoagulant therapy.

Revista medica de Chile, 2007
H, ALESSANDRI, H, DUCCI
openaire   +3 more sources